Dihydromyricetin induces mouse hepatoma Hepal‑6 cell apoptosis via the transforming growth factor‑β pathway

Liu,Bin; Zhou,Wei; Chen,Xiaofeng; Xu,Fengming; Chen,Yinqin; Liu,Jie; Zhang,Qingyu; Bao,Shiting; Chen,Nianping; Li,Mingyi; Zhu,Runzhi

doi:10.3892/mmr.2014.2891

Dihydromyricetin induces mouse hepatoma Hepal‑6 cell apoptosis via the transforming growth factor‑β pathway

Authors:
- Bin Liu
- Wei Zhou
- Xiaofeng Chen
- Fengming Xu
- Yinqin Chen
- Jie Liu
- Qingyu Zhang
- Shiting Bao
- Nianping Chen
- Mingyi Li
- Runzhi Zhu
View Affiliations

Affiliations: Laboratory of Hepatobiliary Surgery, Zhanjiang Key Laboratory of Hepatobiliary Diseases, Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China, Department of Pediatrics, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China, Department of Interventional Medicine, Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong 524001, P.R. China
Published online on: November 6, 2014 https://doi.org/10.3892/mmr.2014.2891
Pages: 1609-1614
Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY_NC 3.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Dihydromyricetin (DHM) is a flavonoid compound which possesses potent antitumor activity. In the present study, it was demonstrated that DHM significantly inhibited proliferation and induced apoptosis in mouse hepatocellular carcinoma Hepal‑6 cells. Transforming growth factor β (TGF‑β) is recognized as a major profibrogenic cytokine and is therefore a common target for drugs in the treatment of liver disease. The present study aimed to investigate whether TGF‑β was involved in DHM‑triggered cell‑viability inhibition and apoptosis induction. An MTT assay was used to evaluate the viability of Hepal‑6 cells following DHM treatment. TGF‑β signalling is mediated by Smads and nicotinamide adenine dinucleotide phosphate oxidase 4 (NOX4) is a crucial regulator of reactive oxygen species ROS production. TGF‑β, Smad3, phosphorylated (p)‑Smad2/3 and NOX4 protein expression levels were evaluated by western blot analysis. TGF‑β and NOX4 gene expression levels were determined by quantitative polymerase chain reaction. The results indicated that DHM downregulated TGF‑β, Smad3, p‑Smad2/3 and NOX4 in a concentration‑dependent manner. A cell counting assay indicated that DHM also inhibited Hepal‑6 cell growth in a concentration‑dependent manner. TGF‑β expression was significantly decreased following DHM treatment. In conclusion, the results of the present study defined and supported a novel function for DHM, indicating that it induced cell apoptosis by downregulating ROS production via the TGF‑β/Smad3 signaling pathway in mouse hepatocellular carcinoma Hepal‑6 cells.

View Figures

View References

1	Wu S, Liu B, Zhang Q, et al: Dihydromyricetin reduced Bcl-2 expression via p53 in human hepatoma hepg2 cells. PLoS One. 8:e768862013. View Article : Google Scholar : PubMed/NCBI
2	Li H, Li Y, Zhang Y, Shi H, Hu W and Zhang Z: Comparison of refluxing, ultrasonic-and microwave-assisted extraction of dihydromyricetin from Ampelopsis grossedentata. J AOAC Int. 91:1278–1283. 2008.
3	Ye J, Guan Y, Zeng S and Liu D: Ampelopsin prevents apoptosis induced by H2O2 in MT-4 lymphocytes. Planta Med. 74:252–257. 2008. View Article : Google Scholar : PubMed/NCBI
4	Kundaković K, Stanojković T, Milenković M, Grubin J, Juranić Z, Stevanović B and Kovačević N: Cytotoxic, antioxidant, and antimicrobial activities of Ampelopsis brevipedunculata and Parthenocissus tricuspidata (Vitaceae). Arch Biol Sci. 60:641–647. 2008. View Article : Google Scholar
5	Zhou Y, Shu F, Liang X, et al: Ampelopsin induces cell growth inhibition and apoptosis in breast cancer cells through ROS generation and endoplasmic reticulum stress pathway. PLoS One. 9:e890212014. View Article : Google Scholar : PubMed/NCBI
6	Kou X, Shen K, An Y, Qi S, Dai WX and Yin Z: Ampelopsin inhibits H₂O₂-induced apoptosis by ERK and Akt signaling pathways and up-regulation of heme oxygenase-1. Phytother Res. 26:988–994. 2012. View Article : Google Scholar
7	Qi S, Xin Y, Guo Y, Diao Y, Kou X, Luo L and Yin Z: Ampelopsin reduces endotoxic inflammation via repressing ROS-mediated activation of PI3K/Akt/NF-κB signaling pathways. Int Immunopharmacol. 12:278–287. 2012. View Article : Google Scholar
8	Jeon SH, Chun W, Choi YJ and Kwon YS: Cytotoxic constituents from the bark of Salix hulteni. Arch Pharm Res. 31:978–982. 2008. View Article : Google Scholar : PubMed/NCBI
9	Zhou FZ, Zhang XY and Guo Y: Anti-proliferation effect of combining dihydromyricetin and adriamycin on MDA-MB-231 cell in vitro. Journal of Hubei University for Nationalities (Medical Edition). 4:0012010.
10	Guo X, Zhu K, Zhang H and Yao H: Anti-tumor activity of a novel protein obtained from tartary buckwheat. Int J Mol Sci. 11:5201–5211. 2010. View Article : Google Scholar : PubMed/NCBI
11	Zhang QY, Li R, Zeng GF, et al: Dihydromyricetin inhibits migration and invasion of hepatoma cells through regulation of MMP-9 expression. World J Gastroenterol. 20:10082–10093. 2014. View Article : Google Scholar : PubMed/NCBI
12	Busse A and Keilholz U: Role of TGF-β in melanoma. Curr Pharm Biotechnol. 12:2165–2175. 2011. View Article : Google Scholar : PubMed/NCBI
13	Perrot CY, Javelaud D and Mauviel A: Insights into the transforming growth factor-β signaling pathway in cutaneous melanoma. Ann Dermatol. 25:135–144. 2013. View Article : Google Scholar : PubMed/NCBI
14	Moustakas A, Souchelnytskyi S and Heldin CH: Smad regulation in TGF-beta signal transduction. J Cell Sci. 114(Pt 24): 4359–4369. 2001.
15	Varelas X, Samavarchi-Tehrani P, Narimatsu M, et al: The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway. Developmental cell. 19:831–844. 2010. View Article : Google Scholar
16	Brown DI and Griendling KK: Nox proteins in signal transduction. Free Radic Biol and Med. 47:1239–1253. 2009. View Article : Google Scholar
17	Tobar N, Guerrero J, Smith PC and Martínez J: NOX4-dependent ROS production by stromal mammary cells modulates epithelial MCF-7 cell migration. Br J Cancer. 103:1040–1047. 2010. View Article : Google Scholar : PubMed/NCBI
18	Boudreau HE, Emerson SU, Korzeniowska A, Jendrysik MA and Leto TL: Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor β-dependent manner: a new contributor to HCV-induced oxidative stress. J Virol. 83:12934–12946. 2009. View Article : Google Scholar : PubMed/NCBI
19	Barnes JL and Gorin Y: Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases. Kidney Int. 79:944–956. 2011. View Article : Google Scholar : PubMed/NCBI
20	Liu R-M and Gaston Pravia K: Oxidative stress and glutathione in TGF-β-mediated fibrogenesis. Free Radical Biology and Medicine. 48:1–15. 2010. View Article : Google Scholar
21	Pike LS, Smift AL, Croteau NJ, Ferrick DA and Wu M: Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta. 1807.726–734. 2011.
22	Kisseleva T and Brenner DA: Mechanisms of fibrogenesis. Exp Biol Med (Maywood). 233:109–122. 2008. View Article : Google Scholar
23	Pérez-Gómez E, Del Castillo G, Santibáñez JF, Lopez-Novoa JM, Bernabéu C and Quintanilla M: The role of the TGF-β coreceptor endoglin in cancer. Scientific World Journal. 10:2367–2384. 2010. View Article : Google Scholar
24	Baek HJ, Pishvaian MJ, Tang Y, Kim TH, Yang S, Zouhairi ME, Mendelson J, Shetty K, Kallakury B, Berry DL, et al: Transforming growth factor-β adaptor, β2-spectrin, modulates cyclin dependent kinase 4 to reduce development of hepatocellular cancer. Hepatology. 53:1676–1684. 2011. View Article : Google Scholar : PubMed/NCBI
25	Taatjes DJ: The human Mediator complex: a versatile, genome-wide regulator of transcription. Trends Biochem Sci. 35:315–322. 2010. View Article : Google Scholar : PubMed/NCBI
26	Moses H and Barcellos-Hoff MH: TGF-beta biology in mammary development and breast cancer. Cold Spring Harbor Perspect Biol. 3:a0032772011. View Article : Google Scholar
27	Wiercinska E, Naber HP, Pardali E, van der Pluijm G, van Dam H and ten Dijke P: The TGF-β/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Cancer Res Treat. 128:657–666. 2011. View Article : Google Scholar
28	Petersen M, Pardali E, Van Der Horst G, Cheung H, van den Hoogen C, van der Pluijm G and Ten Dijke P: Smad2 and Smad3 have opposing roles in breast cancer bone metastasis by differentially affecting tumor angiogenesis. Oncogene. 29:1351–1361. 2010. View Article : Google Scholar
29	Dzwonek J, Preobrazhenska O, Cazzola S, Conidi A, Schellens A, van Dinther M, Stubbs A, Klippel A, Huylebroeck D, ten Dijke P and Verschueren K: Smad3 is a key nonredundant mediator of transforming growth factor beta signaling in Nme mouse mammary epithelial cells. Mol Cancer Res. 7:1342–1353. 2009. View Article : Google Scholar : PubMed/NCBI
30	Szatrowski TP and Nathan CF: Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Res. 51:794–798. 1991.PubMed/NCBI
31	Bierie B and Moses HL: Gain or loss of TGFbeta signaling in mammary carcinoma cells can promote metastasis. Cell Cycle. 8:3319–3327. 2009. View Article : Google Scholar : PubMed/NCBI
32	Bierie B, Chung CH, Parker JS, Stover DG, Cheng N, Chytil A, Aakre M, Shyr Y and Moses HL: Abrogation of TGF-beta signaling enhances chemokine production and correlates with prognosis in human breast cancer. J Clin Invest. 119:1571–1582. 2009. View Article : Google Scholar : PubMed/NCBI
33	Yang L, Huang J, Ren X, Gorska AE, Chytil A, Aakre M, Carbone DP, Matrisian LM, Richmond A, Lin PC and Moses HL: Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. Cancer Cell. 13:23–35. 2008. View Article : Google Scholar : PubMed/NCBI
34	Giannelli G, Mazzocca A, Fransvea E, Lahn M and Antonaci S: Inhibiting TGF-β signaling in hepatocellular carcinoma. Biochim Biophys Acta. 1815.214–223. 2011.
35	Aon MA, Cortassa S and O’Rourke B: Redox-optimized ROS balance: a unifying hypothesis. Biochim Biophys Acta. 1797:865–877. 2010. View Article : Google Scholar : PubMed/NCBI
36	Parga J, Rodríguez-Pallares J, Joglar B, Diaz-Ruiz C, Guerra M and Labandeira-Garcia JL: Effect of inhibitors of NADPH oxidase complex and mitochondrial ATP-sensitive potassium channels on generation of dopaminergic neurons from neurospheres of mesencephalic precursors. Dev Dyn. 239:3247–3259. 2010. View Article : Google Scholar : PubMed/NCBI
37	Li S, Tabar SS, Malec V, Eul BG, Klepetko W, Weissmann N, Grimminger F, Seeger W, Rose F and Hänze J: NOX4 regulates ROS levels under normoxic and hypoxic conditions, triggers proliferation, and inhibits apoptosis in pulmonary artery adventitial fibroblasts. Antioxid Redox Signal. 10:1687–1698. 2008. View Article : Google Scholar : PubMed/NCBI
38	Liu RM, Choi J, Wu JH, Gaston Pravia KA, Lewis KM, Brand JD, Mochel NS, Krzywanski DM, Lambeth JD, Hagood JS, et al: Oxidative modification of nuclear mitogen-activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblasts. J Biol Chem. 285:16239–16247. 2010. View Article : Google Scholar : PubMed/NCBI
39	Liu R-M and Gaston Pravia K: Oxidative stress and glutathione in TGF-β-mediated fibrogenesis. Free Radic Biol Med. 48:1–15. 2010. View Article : Google Scholar
40	Hecker L, Vittal R, Jones T, Jagirdar R, Luckhardt TR, Horowitz JC, Pennathur S, Martinez FJ and Thannickal VJ: NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med. 15:1077–1081. 2009. View Article : Google Scholar : PubMed/NCBI